Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Selectis Health (GBCS) Change in Acquisitions & Divestments (2019)

Selectis Health's Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $100.0 for Q4 2019.

Quarterly results put Change in Acquisitions & Divestments at $100.0 for Q4 2019, changed N/A from a year ago — trailing twelve months through Dec 2019 was $151141.0 (changed N/A YoY), and the annual figure for FY2019 was $151141.0, down 44.92%.
Change in Acquisitions & Divestments for Q4 2019 was $100.0 at Selectis Health, down from $151041.0 in the prior quarter.
In the past five years, Change in Acquisitions & Divestments ranged from a high of $151041.0 in Q1 2019 to a low of $100.0 in Q4 2019.